Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6595002 | 0.95 | CHRM1 (0.49) | TACR2CHRM1HRH1KCNH2 | |
| SCHEMBL6597468 | 0.93 | TACR2 (0.45) | TACR2 | |
| SCHEMBL6592353 | 0.93 | TACR2 (0.51) | TACR2CHRM1HRH1KCNH2 | |
| SCHEMBL6596392 | 0.92 | TACR2 (0.49) | TACR2CHRM1HRH1KCNH2 | |
| SCHEMBL6593467 | 0.92 | LMNA (0.48) | TACR2CHRM1HRH1KCNH2 | |
| SCHEMBL6596599 | 0.92 | CHRM1 (0.47) | TACR2CHRM1HRH1KCNH2 | |
| SCHEMBL6596664 | 0.92 | TACR2 (0.46) | TACR2 | |
| SCHEMBL6597801 | 0.91 | TACR2 (0.45) | TACR2 | |
| SCHEMBL6595621 | 0.91 | TACR2 (0.50) | TACR2CHRM1HRH1KCNH2 | |
| SCHEMBL6594702 | 0.91 | HRH1 (0.43) | CHRM1HRH1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-0888338-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997030991-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-28 | — | — | WO | disclosed |